Recent Updates
Recently added Catalysts

Biotech Drugs Starting With K

Every drug page whose name starts with this letter, grouped by the company developing it.
Updated 2026-09-21

80 of the 11,685 drugs in development that BiopharmaWatch tracks have a name starting with K. They are grouped by the company developing them; each link opens the drug's page with its phase, indication, clinical trials, upcoming catalysts and probability of approval. Browse another letter below, or every company on the companies A to Z page.

AbbVie Inc.ABBV

Akebia Therapeutics, Inc.AKBA

Amneal Pharmaceuticals, Inc.AMRX

AstraZeneca PLCAZN

AtaiBeckley Inc.ATAI

Bausch + Lomb CorporationBLCO

Bayer AGBAYRY

BioMarin Pharmaceutical Inc.BMRN

Bristol-Myers Squibb CompanyBMY

Cardinal Health, Inc.CAH

Celldex Therapeutics, Inc.CLDX

Cumberland Pharmaceuticals Inc.CPIX

Gilead Sciences, Inc.GILD

GSK plcGSK

Johnson & JohnsonJNJ

Kailera Therapeutics, Inc.KLRA

KALA BIO, Inc.KALA

KalVista Pharmaceuticals, Inc.KALV

Kamada Ltd.KMDA

Karyopharm Therapeutics Inc.KPTI

Keros Therapeutics, Inc.KROS

Kezar Life Sciences, Inc.KZR

Kiniksa Pharmaceuticals International, plcKNSA

Kiora Pharmaceuticals, Inc.KPRX

Kodiak Sciences IncKOD

Korro Bio, Inc.KRRO

Krystal Biotech, Inc.KRYS

Kymera Therapeutics, Inc.KYMR

Kyverna Therapeutics, Inc.KYTX

Merck & Company, Inc.MRK

MIRA Pharmaceuticals, Inc.MIRA

Novartis AGNVS

Novo Nordisk A/SNVO

Pfizer, Inc.PFE

Roivant Sciences Ltd.ROIV

SanofiSNY

Sunshine Biopharma Inc.SBFM

TuHURA Biosciences, Inc.HURA

Zevra Therapeutics, Inc.ZVRA